Cargando…
Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage
BACKGROUND: CCR5-using (r5) HIV-1 predominates during asymptomatic disease followed by occasional emergence of CXCR4-using (x4) or dual tropic (r5x4) virus. We examined the contribution of the x4 and r5 components to replicative fitness of HIV-1 isolates. METHODS: Dual tropic r5x4 viruses were predi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592561/ https://www.ncbi.nlm.nih.gov/pubmed/26435727 http://dx.doi.org/10.1186/s12981-015-0066-7 |
_version_ | 1782393208084365312 |
---|---|
author | Nankya, Immaculate L Tebit, Denis M Abraha, Awet Kyeyune, Fred Gibson, Richard Jegede, Oyebisi Nickel, Gabrielle Arts, Eric J |
author_facet | Nankya, Immaculate L Tebit, Denis M Abraha, Awet Kyeyune, Fred Gibson, Richard Jegede, Oyebisi Nickel, Gabrielle Arts, Eric J |
author_sort | Nankya, Immaculate L |
collection | PubMed |
description | BACKGROUND: CCR5-using (r5) HIV-1 predominates during asymptomatic disease followed by occasional emergence of CXCR4-using (x4) or dual tropic (r5x4) virus. We examined the contribution of the x4 and r5 components to replicative fitness of HIV-1 isolates. METHODS: Dual tropic r5x4 viruses were predicted from average HIV-1 env sequences of two primary subtype C HIV-1 isolates (C19 and C27) and from two patient plasma samples (B12 and B19). Chimeric Env viruses with an NL4-3 backbone were constructed from the B12 and B19 env sequences. To determine replicative fitness, these primary and chimeric dual tropic HIV-1 were then competed against HIV-1 reference isolates in U87.CD4 cells expressing CXCR4 or CCR5 or in PBMCs ± entry inhibitors. Contribution of the x4 and r5 clones within the quasispecies of these chimeric or primary HIV-1 isolates were then compared to the frequency of x4, r5, and dual tropic clones within the quasispecies as predicted by phenotypic assays, clonal sequencing, and 454 deep sequencing. RESULTS: In the primary HIV-1 isolates (C19 and C27), subtype C dual tropic clones dominated over x4 clones while pure r5 clones were absent. In two subtype B chimeric viruses (B12 and B19), r5 clones were >100-fold more abundant than x4 or r5/x4 clones. The dual tropic C19 and C27 HIV-1 isolates outcompeted r5 primary HIV-1 isolates, B2 and C3 in PBMCs. When AMD3100 was added or when only U87.CD4.CCR5 cells were used, the B2 and C3 reference viruses now out-competed the r5 component of the dual tropic C19 and C27. In contrast, the same replicative fitness was observed with dualtropic B12 and B19 HIV-1 isolates relative to x4 HIV-1 A8 and E6 or the r5 B2 and C3 viruses, even when the r5 or x4 component was inhibited by maraviroc (or AMD3100) or in U87.CD4.CXCR4 (or CCR5) cells. CONCLUSIONS: In the dual tropic HIV-1 isolates, the x4 replicative fitness is higher than r5 clones but the x4 or x4/r5 clones are typically at low frequency in the intrapatient virus population. Ex vivo HIV propagation promotes outgrowth of the x4 clones and provides an over-estimate of x4 dominance in replicative fitness within dual tropic viruses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12981-015-0066-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4592561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45925612015-10-04 Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage Nankya, Immaculate L Tebit, Denis M Abraha, Awet Kyeyune, Fred Gibson, Richard Jegede, Oyebisi Nickel, Gabrielle Arts, Eric J AIDS Res Ther Research BACKGROUND: CCR5-using (r5) HIV-1 predominates during asymptomatic disease followed by occasional emergence of CXCR4-using (x4) or dual tropic (r5x4) virus. We examined the contribution of the x4 and r5 components to replicative fitness of HIV-1 isolates. METHODS: Dual tropic r5x4 viruses were predicted from average HIV-1 env sequences of two primary subtype C HIV-1 isolates (C19 and C27) and from two patient plasma samples (B12 and B19). Chimeric Env viruses with an NL4-3 backbone were constructed from the B12 and B19 env sequences. To determine replicative fitness, these primary and chimeric dual tropic HIV-1 were then competed against HIV-1 reference isolates in U87.CD4 cells expressing CXCR4 or CCR5 or in PBMCs ± entry inhibitors. Contribution of the x4 and r5 clones within the quasispecies of these chimeric or primary HIV-1 isolates were then compared to the frequency of x4, r5, and dual tropic clones within the quasispecies as predicted by phenotypic assays, clonal sequencing, and 454 deep sequencing. RESULTS: In the primary HIV-1 isolates (C19 and C27), subtype C dual tropic clones dominated over x4 clones while pure r5 clones were absent. In two subtype B chimeric viruses (B12 and B19), r5 clones were >100-fold more abundant than x4 or r5/x4 clones. The dual tropic C19 and C27 HIV-1 isolates outcompeted r5 primary HIV-1 isolates, B2 and C3 in PBMCs. When AMD3100 was added or when only U87.CD4.CCR5 cells were used, the B2 and C3 reference viruses now out-competed the r5 component of the dual tropic C19 and C27. In contrast, the same replicative fitness was observed with dualtropic B12 and B19 HIV-1 isolates relative to x4 HIV-1 A8 and E6 or the r5 B2 and C3 viruses, even when the r5 or x4 component was inhibited by maraviroc (or AMD3100) or in U87.CD4.CXCR4 (or CCR5) cells. CONCLUSIONS: In the dual tropic HIV-1 isolates, the x4 replicative fitness is higher than r5 clones but the x4 or x4/r5 clones are typically at low frequency in the intrapatient virus population. Ex vivo HIV propagation promotes outgrowth of the x4 clones and provides an over-estimate of x4 dominance in replicative fitness within dual tropic viruses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12981-015-0066-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-03 /pmc/articles/PMC4592561/ /pubmed/26435727 http://dx.doi.org/10.1186/s12981-015-0066-7 Text en © Nankya et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Nankya, Immaculate L Tebit, Denis M Abraha, Awet Kyeyune, Fred Gibson, Richard Jegede, Oyebisi Nickel, Gabrielle Arts, Eric J Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage |
title | Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage |
title_full | Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage |
title_fullStr | Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage |
title_full_unstemmed | Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage |
title_short | Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage |
title_sort | defining the fitness of hiv-1 isolates with dual/mixed co-receptor usage |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592561/ https://www.ncbi.nlm.nih.gov/pubmed/26435727 http://dx.doi.org/10.1186/s12981-015-0066-7 |
work_keys_str_mv | AT nankyaimmaculatel definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage AT tebitdenism definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage AT abrahaawet definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage AT kyeyunefred definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage AT gibsonrichard definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage AT jegedeoyebisi definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage AT nickelgabrielle definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage AT artsericj definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage |